- Report
- September 2023
- 120 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- June 2023
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- April 2024
- 185 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- January 2024
- 175 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4770EUR$4,950USD£4,103GBP
- Report
- March 2018
- 179 Pages
Global
From €1325EUR$1,375USD£1,140GBP
€2650EUR$2,750USD£2,279GBP
- Report
- May 2023
- 260 Pages
Global
From €2554EUR$2,650USD£2,197GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- August 2022
United States
From €1869EUR$1,940USD£1,608GBP
- Report
- August 2022
Global
From €761EUR$790USD£655GBP
- Report
- August 2021
Global
From €3845EUR$3,990USD£3,307GBP
- Report
- August 2021
Europe
From €3295EUR$3,420USD£2,835GBP
- Report
- February 2021
Global
From €2852EUR$2,960USD£2,453GBP
- Clinical Trials
- January 2020
- 318 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- August 2022
- 376 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- June 2022
- 65 Pages
Global
From €4813EUR$4,995USD£4,140GBP
The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more